The fracture risk assessment tool (FRAX) has become the most popular predictor in clinical practice since it was developed by the World Health Organization in 2008, but a revision aims to resolve some ...

DENVER — Substantial reductions in fracture risk in postmenopausal women with osteoporosis seen after 18 months of treatment with the new osteoanabolic drug abaloparatide (Tymlos, Radius Health) are ...

Over half the women deemed very high risk are receiving treatment with therapies not recommended as first-line.

Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...

Robot-assisted fracture reduction surgery represents a significant advancement in orthopaedic interventions, utilising robotics to achieve precise alignment of fractured bones. This technology ...

Fractures of the distal radius can be treated with below-elbow or above-elbow casts, however below-elbow casts may be associated with better radiological outcomes, based on results of a prospective ...

Overall, treatments that were associated with the greatest relative risk reduction in fragility fractures included teriparatide, abaloparatide, denosumab, romosozumab and most bisphosphonate. A ...

Please provide your email address to receive an email when new articles are posted on . Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for ...

Giving zoledronate every 18 months for 6 years reduced the risk of fragility fractures—both vertebral and nonvertebral—in older women with hip bone mineral density indicating osteopenia, a ...

Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, scientists say higher ...